report

rate

Palisade Bio Inc

management

$PALI the entire board is a scam with the baggies who were scanned by management and the whites of Wall Street

$PALI ‘s management is biggest loser of 2023.

$PALI garbage company with even worse management.

$PALI worst cheap management who doesn&#39;t know how to negotiate deal.

$PALI I blame the management as the cheaply negotiated a deal with the shorts.

Poor management got tricked by these shorts/under writers to issue a cheap offer.

Poor management doesn’t know how to negotiate a deal with new investors.

$PALI POS garbage bio with scumbag maggots for management and BOD

It’s led by shit management in the past with criminal activities without a doubt.

crash

loss

pump-and-dump

$PALI 2.41-2.25 instant algo dump..  Comical

$PALI  Another fake ass pump in the morning.

but a pump and dump crap shoot, day in and day out.

$PALI Another one that badly needs a pump.

trust

hold

$PALI  $$$$$$$$$$$ in the 💰
BUY, HOLD, WAIT.

$PALI I’m telling you all .. hold and we all will bank on it .. $10

profit

$PALI Check into ✅ SHFS✅ 
Earnings around the corner with Postive EPS and net profit margin of 45%.

$PALI going to keep averaging in this bitch until I make a profit. 😂

$MULN buy some $PALI and bring profits back to $MULN 🤓

$COSM bring profits back to $pali everyone !!!

Called $PALI for 90%+ profits in a single day!

With just some volume on the positive, this one should go big.

$MULN $OPGN $PALI $IWM   Grateful for big things, small things, and every thing in between.

Think we see a big pop to the upside this week.

$PALI Miam miam good consolidation, its about to pop big not gonna lie!

$PALI I love waking up and wondering if today is the day for big winnings 🤑

but today was very very good , the gaps we&#39;re all filled nicely so This shows a nice solid uptrend with no crazy big drops.

$PALI 2 big buys at the close…something is brewing here…

This is the best scenario before a big upswing.Just be patient

$HTGM afterhours party time

$PIK ran again, no surprise stays awesome

$PALI basing hard for big pop 

$VS basing same; need absorption; will get it

$FUV could launch amazingly ⬆️

Htgm is today afterhours play idea, thin and looks ready 👀 check it imo

Goldman Sachs Group, Inc.

scam

Grind The Federal Reserve in the garbage disposal.

$GS Investing in this scam stock is like playing a game of chance with your money.

$GS this garbage will underperform all day and close at 318

target

Bunch of rat bastards with pie in the sky price targets and manipulation

$GS scam cunts , they have the worse price targets t manipulation price action.

trading

↳ Why are you paying to be in a Trading Room?

Goldman Sachs is under capitalized and illegally using client money for trading

$GS huge amounts of risky trading which they sucked at last quarter.

$GS 100% spam, lies, et al, not the first time fake dmj has been used, ignore, report this fraudster ron, he&#39;s no guru, my friends, good health and trading to all.

$GS sucks try banking, trading and investing with SoFi come over to $SOFI big banks suck!

$GS shares down -6% for the worst day in 364 trading days (a day shy of the anniversary). Pulling down other banks ($KBE)

analyst

Goldman Sachs missed analysts’ estimates on both the top and bottom lines, with loan loss provisions coming in higher than expected.

$GS traah pos, fk them corrupt scums fake price analyst

business-result

but you can’t be down $3.94B QoQ from last year when you have industry peers with less clout $JPM $BAC both pushing out over $2B in profits for the same quarter. Embarrassing.

$GS  atrocious quarter … these pigs overpay themselves richly no matter what their business is doing … no cost control in the compensation and benefits area … embarrassing fail as compared with rival Morgan Stanley

4th straight quarter of declining profits and these guys are heroes???!

$GS amazing this isn&#39;t down 20% on that report

Shares gained +17.9% since the last report https://tinyurl.com/y82f24mq

LOOKS GREAT Technically..Do you know when $GS reports

$SPY no rate hike next week $GS now said, very interesting.

$GS interest rates go up..good for $XLF .

$GS at this rate the stock will close flat 😂

$SPY I love how $GS expectd the Feds to do what they say 😂 clowns .

$BTC.X $DKNG $GS $QQQ $SPY 
“The world is saying something” that’s a great quote. Cheers.

$QQQ $SPY $DIA $C $GS the banks are all backed with cash, so in my opinion there are no more problems.

$SPY $QQQ $GS well that was easy for bulls today.

$AABB ok new favorite one $AMC $APE.X $SPY $GS  notice the golden shovel

bear

.Ready For A Nice Move $25+++ Lots Of Bear Meat Over There!!! DWAC

$GS I dont see too much more downside, bears are getting greedy, in one week we will be back by $360+

🐻❤😈 your 24x7 active short trader care bear specialist for profits  .

$GS tomorrow another bear victory 🐻🐻🐻🐻🐻🐻

Nice fade  on ER 50/50 bet bears got paid this time!

$GS where all my morning bears at 🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻🐻

A nice bear rally next week and overall strength until gdp and end of month QT.

Cassava Sciences Inc

action

The day to day price action of this limp dick is more painful to watch than slugs breeding.

$SAVA , this daily one way action is depressing.

Zero confidence in management based on both recent actions and historical issues with the FDA. 2.

$SAVA We may get frustrated with volatility, manipulation, and irregular daily price action

price

This is sickening that these crooks can manipulate the price like this. !!!

He invites shorts to destroy stock price.. pathetic!

Some had to drop in price a little first!

new employee mr. cook must be pissed as this is lower price than the shares he got it for.

All.u did was dilute the pps 
..and release to prs to kill the stock price and momentum  
 You did so well..you fxuking scumbag.

I hate the stock price runup leading to an announcement.

data

- 
$AVXL in comparison, boring as hell - whenever Missling talks people fall asleep and holding back data and further readouts without any logical explanation are red flags -

$SAVA 
Pyggie here was bullish a few days ago, folded like a pussy because he can’t read data, and now spews FUD, like a spoiled child, because he’s worried he may have paper-handed a monster.

but offer only the “opinion” that there was “possible data manipulation.”

$SAVA longtime biotech investor and my honest experience when a CEO promises good data and there is a long waiting period = not good.

Sentiment matters in this game, and unfortunately, this company has been drug through the mud for so long that good data might just get overlooked.

$SAVA The ironic and sad thing is that this ticker has been abused and manipulated so badly that even if it triples on upcoming data release it still won&#39;t come close to ATH achieved on much less evidence of safety and efficacy.

The CEO belongs in jail with all this pump and dump stock manipulation and data manipulation

just annoying we all get so worked up and insulting when we, the retail investor, can neither move Remi to release data early or in truth, move the SP by buying or selling a few hundred shares.

$SAVA dumb management causing longs to lose confidence, you dont change the date of data release every few weeks, just give a date when you are certain and stick with that, its that simple

BIIB with a 27% chance of no decline - so bad, how can they even publish data like that.

patient

however, if you are a family member of Alz patient think about how fatiguing emotionally and financially it is to change diapers, have your name forgotten, or even have to take a license away from an otherwise healthy person.

but your day will come when you will pay back way more than the damage you have caused and the lives you have threatened from being treated for a debilitating disease.

$ALZN $ATHA $ORMP $SAVA $SPRC yes then go back to your scam board clown no need to trap others in this scam .. we know what value SAVA brings to their AD patients

Lecanemab approved - IV  infusion..increased infection risk, inconvenient for patients with MD&#39;s fully aware 
of side effects: brain swelling and bleeding. 2.

Eventually, the  
AD patient is unable to perform daily functions.

But the monoclonal antibody treatment also carries risks of brain swelling and bleeding.

$BIIB - lied and tried to push their bad drug Aduhelm on unsuspecting patients (one of which is a family member of mine).

3 deaths in 1900 trial patients.. how many deaths is our FDA going to inflict on millions of folks who are supposed to take this death drugs that also happen to have near-zero efficacy?? SMH

Avxl, not good they didn&#39;t have an agreement in place “plan for approval“ before they started the test fase 2b 500 patients.

$SAVA It&#39;s not only CRUEL for anyone to be prescribing any of these MABs for AD patients, it&#39;s impractical for both patients and the healthcare system in general.

application

$SAVA Words  to  to  ignorant,  never  hype  a  employee  from  fda,  shady  shiat! 🤡🤡🤡😂😂😂

It doesn&#39;t matter if drugs for terminal illnesses, have been approved after 6 months, because there is endless manipulation here, and this waiting game is based on either FDA approval or denial based on corruption at the agency?

This is such crap with the FDA my Father died a year ago from it

$BIIB $SAVA You would need uncommon patience to not be crazy mad at the system for this shenanigan approval process and decision from the FDA.

Idiots with no respect for integrity continues  to run 
wild within the FDA.

$SAVA once again we got fu*ked by the evil BIIB + FDA.

$SAVA THIS is how corrupt our FDA and state medical boards are.

$BIIB $SAVA  
I tell ya why - FDA is corrupt deep in its root, period!

$SAVA $44 tomorrow with positive report and strong market?

People genuinely interested in buying here in case that the report be good.

Should be a solid report and play in the coming weeks.

$SAVA Interesting 46.60% SAVA Increase in Ownership  report by Morgan Stanley. ✨🚀

Tomorrow FOMC and Fed rate, $SPX will be hot again

but love the 3.75% int rate on funds there 
  
   
LOADED UP IN SRPT HERE WITH ALL OF THESE CALLS BEING BOUGHT!!!

Bernardino is a 5-star analyst with an average return of 19.9% and a 32.4% success rate.

But the company actually has never seen before wonderful results.

And, make no mistake, the result are impressive.

It is the best results that have been seen in AD.

This could be huge in eliminating artificial FUD against the top-line results.

$SAVA Market is moving higher as SAVA is expecting data results.

Anavex is late like the sun comes up and still produces great results.

MOST IMPORTANTLY, THE RESULTS MUST HAVE BEEN GOOD AND PROMISING at each snapshot that leads Remi to use the word &quot;Thrilled&quot; in Dec 6 PR.

Data tells me no safety issues, with a possible large therapeutic window.

Then they dropped the “good” totally “not disappointing” data that Remi was so “Thrilled” about.

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

SAVA data gets analyzed by multiple different labs and shows its cognition improvement in mild AD cases, safe and well-tolerated

$SAVA I love not being able to hold $28 off data that will keep it pinned here until 2024.

but the data to date would predict continued efficacy that will be nigh on impossible to ignore.

$SAVA Institutional buying says data is good!! !

I’ll keep buying until data comes out…

Excited for the next data unveiling….bring it on!

$SAVA “Treatment also eased depression and dementia-related behaviors in patients, two exploratory trial goals, and simufilam was found to be safe and well tolerated.”

This will bring in billions of revenue and it will make the life quality longer for AD patients.

This sub-set of patients improved -4.96 mean points on ADAS-Cog from baseline to month 12.

CURING LEUKEMIA isn&#39;t a fly by night thing with Gamma T Cells and they already have ONE COMPLETE RESPONSE curing someone in Stage 4 nonresponsive to other treatments!

$SAVA this is going to be game changer and first drug to give some relief to AD patients … and will make $BIIB poison AD pills an obsolete

The high number of the patients that went into CMS (which is 80% complete) is reassuring.

but reverses cognitive decline and improves quality of life for the patient AND the FAMILY!

but mostly new hope for all the families and patients with AZ.

Testing still continues, so in my way of thinking the real-world results in patients must be nothing short of excellent.

Top Stocks matching your search for "report rates"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Feb, 3, 2023

Jan, 17, 2023

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Dec, 9, 2022

Dec, 8, 2022

PALI

Palisade Bio Inc

-19.56%

$2.25 - $1.81

GS

Goldman Sachs Group, Inc.

-15.26%

$374.40 - $317.28

Feb, 3, 2023

Jan, 17, 2023

Jan, 13, 2023

Jan, 10, 2023

Nov, 28, 2022

Nov, 8, 2022

SAVA

Cassava Sciences Inc

-13.96%

$29.88 - $25.71

Dec, 9, 2022

Dec, 8, 2022

Nov, 18, 2022

Nov, 1, 2022